{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:33:01Z","timestamp":1790260381461,"version":"4.1.0"},"reference-count":66,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2019,3,31]]},"DOI":"10.2217\/fon-2018-0468","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T15:55:34Z","timestamp":1544802934000},"page":"953-965","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":52,"title":["Nilotinib in the Treatment of Chronic Myeloid Leukemia"],"prefix":"10.1080","volume":"15","author":[{"given":"Tomasz","family":"Sacha","sequence":"first","affiliation":[{"name":"Department of Hematology, Jagiellonian University Hospital, ul. Kopernika 17, 31-501Krak\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Saglio","sequence":"additional","affiliation":[{"name":"Division of Hematology & Internal Medicine, Department of Clinical & Biological Sciences of the University of Turin, \u2018San Luigi Gonzaga\u2019 University Hospital, 10043Orbassano-Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0092"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1609324"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.253"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr060"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23238"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162388"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-501569"},{"key":"e_1_3_2_12_1","article-title":"NCCN Trends\u2122 Highlights: monitoring and managing chronic myelogenous leukemia","author":"Ulrich SL","unstructured":"Ulrich SL . NCCN Trends\u2122 Highlights: monitoring and managing chronic myelogenous leukemia. NCCNwww.nccn.org\/about\/news\/ebulletin\/ebulletindetail.aspx?ebulletinid=546.","journal-title":"NCCN"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11172"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.104"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348110"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.85"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.9020"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70233-3"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483750"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.1680.1680"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.85"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-510396"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511592"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-532341"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V118.21.3770.3770"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603170"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-2601"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0259"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.01.007"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2009.11.008"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.08.026"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003637282"},{"issue":"1","key":"e_1_3_2_33_1","first-page":"211","article-title":"Comparative in vitro cellular data alone is insufficient to predict clinical responses and guide choice of BCR-ABL inhibitor to treat imatinib-resistant chronic myeloid leukemia","volume":"114","author":"Laneuville P","year":"2009","unstructured":"Laneuville P , DiLeaC, MestanJ, YinO, WoodmanRC, ManleyP. Comparative in vitro cellular data alone is insufficient to predict clinical responses and guide choice of BCR-ABL inhibitor to treat imatinib-resistant chronic myeloid leukemia. Blood114(Suppl. 1), 211, Abstract 510 (2009).","journal-title":"Blood"},{"issue":"2","key":"e_1_3_2_34_1","first-page":"260","article-title":"Comparative in vitro cellular data alone is insufficient to guide choice of BCR-ABL inhibitor to treat imatinib-resistant chronic myeloid leukemia (CML)","volume":"94","author":"Laneuville P","year":"2009","unstructured":"Laneuville P , DiLeaC, MestanJ, YinO, ManleyP. Comparative in vitro cellular data alone is insufficient to guide choice of BCR-ABL inhibitor to treat imatinib-resistant chronic myeloid leukemia (CML). Haematologica94(Suppl. 2), 260\u2013261 (2009).","journal-title":"Haematologica"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055104"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083196"},{"key":"e_1_3_2_37_1","unstructured":"Tasigna (nilotinib) [package insert] . Novartis East Hanover NJ USA (2015). www.pharma.us.novartis.com\/sites\/www.pharma.us.novartis.com\/files\/tasigna.pdf."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912614"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.181"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-080689"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-6"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-232595"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4896"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4541.4541"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.92.92"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22037"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr292"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22084"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5580"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23938"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-594432"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.086355"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1266"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694265"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.2914"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.48.5797"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.63"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00196-9"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1337114"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.4547.4547"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.139899"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24120"},{"issue":"1","key":"e_1_3_2_64_1","first-page":"22","article-title":"Stopping tyrosine kinase inhibitors in a very large cohort of European chronic myeloid leukemia patients: results of the EURO-SKI trial","volume":"101","author":"Richter J","year":"2016","unstructured":"Richter J , MahonFX, GuilhotJet al. Stopping tyrosine kinase inhibitors in a very large cohort of European chronic myeloid leukemia patients: results of the EURO-SKI trial. Haematologica101(Suppl. 1), 22; Abstract S145 (2016).","journal-title":"Haematologica"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2604-x"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1094"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.69"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.7073"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2018-0468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:45:17Z","timestamp":1719125117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2018-0468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":66,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,3,31]]}},"alternative-id":["10.2217\/fon-2018-0468"],"URL":"https:\/\/doi.org\/10.2217\/fon-2018-0468","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}